<VariationArchive VariationID="651831" VariationName="NC_000011.10:g.(?_31794610)_(31794829_?)del" VariationType="Deletion" Accession="VCV000651831" Version="8" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2019-08-14" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="652056" VariationID="651831">
      <GeneList>
        <Gene Symbol="PAX6" FullName="paired box 6" GeneID="5080" HGNC_ID="HGNC:8620" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="31789026" stop="31817961" display_start="31789026" display_stop="31817961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="31806339" stop="31839508" display_start="31806339" display_stop="31839508" Strand="-" />
          </Location>
          <OMIM>607108</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX6">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000011.10:g.(?_31794610)_(31794829_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" innerStart="31794610" innerStop="31794829" display_start="31794610" display_stop="31794829" variantLength="220" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" innerStart="31816158" innerStop="31816377" display_start="31816158" display_stop="31816377" variantLength="220" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.(?_31794610)_(31794829_?)del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.(?_31794610)_(31794829_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.(?_31816158)_(31816377_?)del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.(?_31816158)_(31816377_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000011.10:g.(?_31794610)_(31794829_?)del AND multiple conditions" Accession="RCV000807256" Version="8">
        <ClassifiedConditionList TraitSetID="39839">
          <ClassifiedCondition DB="MedGen" ID="C0344542">Aniridia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0344559">Irido-corneo-trabecular dysgenesis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-01-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <DescriptionHistory Dated="2020-04-09">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39839" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3486" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANTERIOR SEGMENT DYSGENESIS 5</ElementValue>
                <XRef Type="MIM" ID="604229" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Irido-corneo-trabecular dysgenesis</ElementValue>
                <XRef ID="Irido-corneo-trabecular+dysgenesis/8682" DB="Genetic Alliance" />
                <XRef ID="204153003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ASGD5</ElementValue>
                <XRef Type="MIM" ID="604229" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7377" />
                <XRef ID="7377" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="708" DB="Orphanet" />
              <XRef ID="C0344559" DB="MedGen" />
              <XRef ID="MONDO:0011414" DB="MONDO" />
              <XRef Type="MIM" ID="604229" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000659" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="315" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aniridia 1</ElementValue>
                <XRef ID="MONDO:0024507" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AN1</ElementValue>
                <XRef Type="MIM" ID="106210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">PAX6-related aniridia occurs either as an isolated ocular abnormality or as part of the Wilms tumor-aniridia-genital anomalies-retardation (WAGR) syndrome. Aniridia is a pan ocular disorder affecting the cornea, iris, intraocular pressure (resulting in glaucoma), lens (cataract and lens subluxation), fovea (foveal hypoplasia), and optic nerve (optic nerve coloboma and hypoplasia). Individuals with aniridia characteristically show nystagmus and impaired visual acuity (usually 20/100 - 20/200); however, milder forms of aniridia with subtle iris architecture changes, good vision, and normal foveal structure do occur. Other ocular involvement may include strabismus and occasionally microphthalmia. Although the severity of aniridia can vary between and within families, little variability is usually observed in the two eyes of an affected individual. WAGR syndrome. The risk for Wilms tumor is 42.5%-77%; of those who develop Wilms tumor, 90% do so by age four years and 98% by age seven years. Genital anomalies in males can include cryptorchidism and hypospadias (sometimes resulting in ambiguous genitalia), urethral strictures, ureteric abnormalities, and gonadoblastoma. While females typically have normal external genitalia, they may have uterine abnormalities and streak ovaries. Intellectual disability (defined as IQ &lt;74) is observed in 70%; behavioral abnormalities include attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, anxiety, depression, and obsessive-compulsive disorder. Other individuals with WAGR syndrome can have normal intellect without behavioral problems.</Attribute>
                <XRef ID="NBK1360" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301534</ID>
                <ID Source="BookShelf">NBK1360</ID>
              </Citation>
              <XRef ID="250923" DB="Orphanet" />
              <XRef ID="C0344542" DB="MedGen" />
              <XRef ID="MONDO:0024507" DB="MONDO" />
              <XRef Type="MIM" ID="106210" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1841347" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_000280.4_11_Deletion (exon 8)|MedGen:C0344542;C0344559" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000947299" DateUpdated="2024-06-09" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. This variant has been observed to be de novo in an individual affected with aniridia (Invitae). This variant is an in-frame deletion of the genomic region encompassing exon 8 of the PAX6 gene. It preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.(?_31816158)_(31816377_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0344542" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0344559" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1841347" TraitType="Disease" MappingType="XRef" MappingValue="C0344542" MappingRef="MedGen">
        <MedGen CUI="C0344542" Name="Aniridia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1841347" TraitType="Disease" MappingType="XRef" MappingValue="C0344559" MappingRef="MedGen">
        <MedGen CUI="C0344559" Name="Irido-corneo-trabecular dysgenesis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

